FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...